How RWE can support drug development during COVID-19 and beyond
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...